HEADER APOPTOSIS 13-JAN-21 7BJ0 TITLE INHIBITOR OF MDM2-P53 INTERACTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE MDM2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DOUBLE MINUTE 2 PROTEIN,HDM2,ONCOPROTEIN MDM2,RING-TYPE E3 COMPND 5 UBIQUITIN TRANSFERASE MDM2,P53-BINDING PROTEIN MDM2; COMPND 6 EC: 2.3.2.27; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MDM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: PLYSS KEYWDS LIGASE, CELL CYCLE, APOPTOSIS, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR P.A.WILLIAMS REVDAT 3 15-MAY-24 7BJ0 1 REMARK REVDAT 2 21-APR-21 7BJ0 1 COMPND SOURCE JRNL REMARK REVDAT 2 2 1 DBREF SEQADV SEQRES HET REVDAT 2 3 1 HETNAM FORMUL HELIX SHEET REVDAT 2 4 1 SITE ATOM REVDAT 1 07-APR-21 7BJ0 0 JRNL AUTH G.CHESSARI,I.R.HARDCASTLE,J.S.AHN,B.ANIL,E.ANSCOMBE, JRNL AUTH 2 R.H.BAWN,L.D.BEVAN,T.J.BLACKBURN,I.BUCK,C.CANO,B.CARBAIN, JRNL AUTH 3 J.CASTRO,B.CONS,S.J.CULLY,J.A.ENDICOTT,L.FAZAL,B.T.GOLDING, JRNL AUTH 4 R.J.GRIFFIN,K.HAGGERTY,S.J.HARNOR,K.HEARN,S.HOBSON, JRNL AUTH 5 R.S.HOLVEY,S.HOWARD,C.E.JENNINGS,C.N.JOHNSON,J.LUNEC, JRNL AUTH 6 D.C.MILLER,D.R.NEWELL,M.E.M.NOBLE,J.REEKS,C.H.REVILL, JRNL AUTH 7 C.RIEDINGER,J.D.ST DENIS,E.TAMANINI,H.THOMAS,N.T.THOMPSON, JRNL AUTH 8 M.VINKOVIC,S.R.WEDGE,P.A.WILLIAMS,N.E.WILSHER,B.ZHANG,Y.ZHAO JRNL TITL STRUCTURE-BASED DESIGN OF POTENT AND ORALLY ACTIVE JRNL TITL 2 ISOINDOLINONE INHIBITORS OF MDM2-P53 PROTEIN-PROTEIN JRNL TITL 3 INTERACTION. JRNL REF J.MED.CHEM. V. 64 4071 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 33761253 JRNL DOI 10.1021/ACS.JMEDCHEM.0C02188 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0222 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 83.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 24168 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1293 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1813 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.71 REMARK 3 BIN R VALUE (WORKING SET) : 0.3690 REMARK 3 BIN FREE R VALUE SET COUNT : 97 REMARK 3 BIN FREE R VALUE : 0.3550 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1527 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 144 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.130 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.119 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.127 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.881 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.967 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.961 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1684 ; 0.009 ; 0.015 REMARK 3 BOND LENGTHS OTHERS (A): 1564 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2300 ; 1.307 ; 1.731 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3669 ; 0.434 ; 1.690 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 201 ; 6.865 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 65 ;41.042 ;21.385 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 286 ;14.352 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;11.003 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 210 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1829 ; 0.003 ; 0.022 REMARK 3 GENERAL PLANES OTHERS (A): 311 ; 0.000 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 17 A 109 REMARK 3 ORIGIN FOR THE GROUP (A): -41.6712 9.4258 -10.4095 REMARK 3 T TENSOR REMARK 3 T11: 0.2349 T22: 0.0885 REMARK 3 T33: 0.4944 T12: -0.0552 REMARK 3 T13: 0.0771 T23: -0.0265 REMARK 3 L TENSOR REMARK 3 L11: 3.9594 L22: 1.5660 REMARK 3 L33: 4.9709 L12: 0.7236 REMARK 3 L13: 3.1450 L23: 1.3475 REMARK 3 S TENSOR REMARK 3 S11: 0.3028 S12: 0.2948 S13: -0.0977 REMARK 3 S21: 0.0131 S22: 0.0104 S23: -0.1277 REMARK 3 S31: -0.1625 S32: 0.5759 S33: -0.3132 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 17 B 110 REMARK 3 ORIGIN FOR THE GROUP (A): -53.5203 9.0695 -16.1305 REMARK 3 T TENSOR REMARK 3 T11: 0.2636 T22: 0.0235 REMARK 3 T33: 0.4701 T12: 0.0465 REMARK 3 T13: 0.0340 T23: -0.0228 REMARK 3 L TENSOR REMARK 3 L11: 2.7385 L22: 1.0446 REMARK 3 L33: 4.2130 L12: -0.1322 REMARK 3 L13: 2.4424 L23: -0.5816 REMARK 3 S TENSOR REMARK 3 S11: 0.2264 S12: 0.1092 S13: -0.0433 REMARK 3 S21: -0.0832 S22: -0.0961 S23: 0.0631 REMARK 3 S31: -0.1700 S32: 0.0002 S33: -0.1303 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED HYDROGENS REMARK 3 HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 4 REMARK 4 7BJ0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1292113461. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-AUG-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0719 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25478 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 83.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.91400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.2M (NH4)2SO4, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 24.32800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 48.65600 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 48.65600 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 24.32800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 12 REMARK 465 PRO A 13 REMARK 465 LEU A 14 REMARK 465 GLY A 15 REMARK 465 SER A 16 REMARK 465 VAL A 110 REMARK 465 ASN A 111 REMARK 465 GLN A 112 REMARK 465 GLN A 113 REMARK 465 GLU A 114 REMARK 465 SER A 115 REMARK 465 SER A 116 REMARK 465 ASP A 117 REMARK 465 SER A 118 REMARK 465 GLY A 119 REMARK 465 THR A 120 REMARK 465 SER A 121 REMARK 465 VAL A 122 REMARK 465 SER A 123 REMARK 465 GLU A 124 REMARK 465 ASN A 125 REMARK 465 GLY B 12 REMARK 465 PRO B 13 REMARK 465 LEU B 14 REMARK 465 GLY B 15 REMARK 465 SER B 16 REMARK 465 ASN B 111 REMARK 465 GLN B 112 REMARK 465 GLN B 113 REMARK 465 GLU B 114 REMARK 465 SER B 115 REMARK 465 SER B 116 REMARK 465 ASP B 117 REMARK 465 SER B 118 REMARK 465 GLY B 119 REMARK 465 THR B 120 REMARK 465 SER B 121 REMARK 465 VAL B 122 REMARK 465 SER B 123 REMARK 465 GLU B 124 REMARK 465 ASN B 125 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TVH A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TVH B 201 DBREF 7BJ0 A 17 125 UNP Q00987 MDM2_HUMAN 17 125 DBREF 7BJ0 B 17 125 UNP Q00987 MDM2_HUMAN 17 125 SEQADV 7BJ0 GLY A 12 UNP Q00987 EXPRESSION TAG SEQADV 7BJ0 PRO A 13 UNP Q00987 EXPRESSION TAG SEQADV 7BJ0 LEU A 14 UNP Q00987 EXPRESSION TAG SEQADV 7BJ0 GLY A 15 UNP Q00987 EXPRESSION TAG SEQADV 7BJ0 SER A 16 UNP Q00987 EXPRESSION TAG SEQADV 7BJ0 ALA A 51 UNP Q00987 LYS 51 ENGINEERED MUTATION SEQADV 7BJ0 GLY B 12 UNP Q00987 EXPRESSION TAG SEQADV 7BJ0 PRO B 13 UNP Q00987 EXPRESSION TAG SEQADV 7BJ0 LEU B 14 UNP Q00987 EXPRESSION TAG SEQADV 7BJ0 GLY B 15 UNP Q00987 EXPRESSION TAG SEQADV 7BJ0 SER B 16 UNP Q00987 EXPRESSION TAG SEQADV 7BJ0 ALA B 51 UNP Q00987 LYS 51 ENGINEERED MUTATION SEQRES 1 A 114 GLY PRO LEU GLY SER SER GLN ILE PRO ALA SER GLU GLN SEQRES 2 A 114 GLU THR LEU VAL ARG PRO LYS PRO LEU LEU LEU LYS LEU SEQRES 3 A 114 LEU LYS SER VAL GLY ALA GLN LYS ASP THR TYR THR MET SEQRES 4 A 114 ALA GLU VAL LEU PHE TYR LEU GLY GLN TYR ILE MET THR SEQRES 5 A 114 LYS ARG LEU TYR ASP GLU LYS GLN GLN HIS ILE VAL TYR SEQRES 6 A 114 CYS SER ASN ASP LEU LEU GLY ASP LEU PHE GLY VAL PRO SEQRES 7 A 114 SER PHE SER VAL LYS GLU HIS ARG LYS ILE TYR THR MET SEQRES 8 A 114 ILE TYR ARG ASN LEU VAL VAL VAL ASN GLN GLN GLU SER SEQRES 9 A 114 SER ASP SER GLY THR SER VAL SER GLU ASN SEQRES 1 B 114 GLY PRO LEU GLY SER SER GLN ILE PRO ALA SER GLU GLN SEQRES 2 B 114 GLU THR LEU VAL ARG PRO LYS PRO LEU LEU LEU LYS LEU SEQRES 3 B 114 LEU LYS SER VAL GLY ALA GLN LYS ASP THR TYR THR MET SEQRES 4 B 114 ALA GLU VAL LEU PHE TYR LEU GLY GLN TYR ILE MET THR SEQRES 5 B 114 LYS ARG LEU TYR ASP GLU LYS GLN GLN HIS ILE VAL TYR SEQRES 6 B 114 CYS SER ASN ASP LEU LEU GLY ASP LEU PHE GLY VAL PRO SEQRES 7 B 114 SER PHE SER VAL LYS GLU HIS ARG LYS ILE TYR THR MET SEQRES 8 B 114 ILE TYR ARG ASN LEU VAL VAL VAL ASN GLN GLN GLU SER SEQRES 9 B 114 SER ASP SER GLY THR SER VAL SER GLU ASN HET TVH A 201 57 HET TVH B 201 57 HETNAM TVH (3~{R})-4-CHLORANYL-3-(4-CHLOROPHENYL)-3-[[1- HETNAM 2 TVH (HYDROXYMETHYL)CYCLOPROPYL]METHOXY]-2-[(4- HETNAM 3 TVH NITROPHENYL)METHYL]ISOINDOL-1-ONE FORMUL 3 TVH 2(C26 H22 CL2 N2 O5) FORMUL 5 HOH *144(H2 O) HELIX 1 AA1 PRO A 20 GLU A 25 1 6 HELIX 2 AA2 LYS A 31 SER A 40 1 10 HELIX 3 AA3 MET A 50 LYS A 64 1 15 HELIX 4 AA4 ASP A 68 GLN A 72 5 5 HELIX 5 AA5 ASP A 80 GLY A 87 1 8 HELIX 6 AA6 GLU A 95 ARG A 105 1 11 HELIX 7 AA7 PRO B 20 GLU B 25 1 6 HELIX 8 AA8 LYS B 31 SER B 40 1 10 HELIX 9 AA9 MET B 50 LYS B 64 1 15 HELIX 10 AB1 GLU B 69 GLN B 72 5 4 HELIX 11 AB2 ASP B 80 GLY B 87 1 8 HELIX 12 AB3 GLU B 95 ARG B 105 1 11 SHEET 1 AA1 3 TYR A 48 THR A 49 0 SHEET 2 AA1 3 LEU A 27 PRO A 30 -1 N VAL A 28 O TYR A 48 SHEET 3 AA1 3 LEU B 107 VAL B 109 -1 O VAL B 108 N ARG A 29 SHEET 1 AA2 2 ILE A 74 TYR A 76 0 SHEET 2 AA2 2 SER A 90 SER A 92 -1 O PHE A 91 N VAL A 75 SHEET 1 AA3 3 LEU A 107 VAL A 108 0 SHEET 2 AA3 3 LEU B 27 PRO B 30 -1 O ARG B 29 N VAL A 108 SHEET 3 AA3 3 TYR B 48 THR B 49 -1 O TYR B 48 N VAL B 28 SHEET 1 AA4 2 ILE B 74 TYR B 76 0 SHEET 2 AA4 2 SER B 90 SER B 92 -1 O PHE B 91 N VAL B 75 SITE 1 AC1 13 LEU A 54 PHE A 55 GLY A 58 GLN A 59 SITE 2 AC1 13 ILE A 61 TYR A 67 HOH A 345 GLU B 52 SITE 3 AC1 13 VAL B 93 HIS B 96 ILE B 99 TYR B 100 SITE 4 AC1 13 HOH B 317 SITE 1 AC2 12 GLU A 52 HIS A 96 TYR A 100 SER B 17 SITE 2 AC2 12 LEU B 54 PHE B 55 GLY B 58 GLN B 59 SITE 3 AC2 12 ILE B 61 TYR B 67 HOH B 343 HOH B 370 CRYST1 96.538 96.538 72.984 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010359 0.005981 0.000000 0.00000 SCALE2 0.000000 0.011961 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013702 0.00000